LONDON–(BUSINESS WIRE)–#GlobalHerpesTreatmentMarket–Technavio has been monitoring the herpes treatment market and it is poised to grow by $ 677.02 mn during 2020-2024, progressing at a CAGR of almost 4% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Click & Get Free sample report in minutes
Impact of COVID-19
The COVID-19 pandemic continues to transform the growth of various industries, however, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. COVID-19 will have a high impact on the herpes treatment market. The market growth in 2020 is likely to increase compared to the market growth in 2019.
Frequently Asked Questions:
-
What are the major trends in the market?
Rising prevalence rate of shingles in the older population is a major trend driving the growth of the market. -
At what rate is the market projected to grow?
The market will accelerate at a CAGR of almost 4% and the incremental growth of the market is anticipated to be $ 677.02 mn.
-
Who are the top players in the market? (Read more…)
Bausch Health Companies Inc., Cipla Inc., Eli Lilly and Co., Gilead Sciences Inc., GlaxoSmithKline Plc, Maruho Co. Ltd., Merck & Co. Inc., Mylan NV, Novartis AG, and Teva Pharmaceutical Industries Ltd., are some of the major market participants.
-
What is the key market driver?
The increasing prevalence of herpes infection is one of the major factors driving the market.
-
How big is the Asia market?
The Asia region will contribute to 38% of the market share.
Related Reports on Health Care Include:
- Capsule Endoscopes Market by Product and Geography – Forecast and Analysis 2020-2024- The capsule endoscopes market size has the potential to grow by USD 160.35 million during 2020-2024, and the market’s growth momentum will accelerate at a CAGR of 7.95%. To get extensive research insights: Click and get FREE sample report in minutes
- China In-Vitro Diagnostics Market by End-user and Application – Forecast and Analysis 2020-2024- The China in-vitro diagnostics market size has the potential to grow by USD 6.93 billion during 2020-2024, and the market’s growth momentum will decelerate at a CAGR of 16.61%. To get extensive research insights: Click and get FREE sample report in minutes
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Bausch Health Companies Inc., Cipla Inc., Eli Lilly and Co., Gilead Sciences Inc., GlaxoSmithKline Plc, Maruho Co. Ltd., Merck & Co. Inc., Mylan NV, Novartis AG, and Teva Pharmaceutical Industries Ltd. are some of the major market participants. The increasing prevalence of herpes infection will offer immense growth opportunities. In a bid to help players strengthen their market foothold, this herpes treatment market forecast report provides a detailed analysis of the leading market vendors. The report also empowers industry honchos with information on the competitive landscape and insights into the different product offerings offered by various companies.
Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Herpes Treatment Market 2020-2024: Segmentation
Herpes Treatment Market is segmented as below:
-
Type
- Herpes Zoster
- Herpes Simplex
-
Geography
- North America
- Europe
- Asia
- ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44343
Herpes Treatment Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The herpes treatment market report covers the following areas:
- Herpes Treatment Market Size
- Herpes Treatment Market Trends
- Herpes Treatment Market Industry Analysis
This study identifies rising prevalence rate of shingles in the older population as one of the prime reasons driving the herpes treatment market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Herpes Treatment Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist herpes treatment market growth during the next five years
- Estimation of the herpes treatment market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the herpes treatment market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of herpes treatment market vendors
Table of Contents:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Herpes zoster – Market size and forecast 2019-2024
- Herpes simplex – Market size and forecast 2019-2024
- Market opportunity by Type
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- Asia – Market size and forecast 2019-2024
- ROW – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive Scenario
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Bausch Health Companies Inc.
- Cipla Inc.
- Eli Lilly and Co.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Maruho Co. Ltd.
- Merck & Co. Inc.
- Mylan NV
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
-
List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/